Pemetrexed and S-1 in Combination With Bevacizumab in Refractory Colorectal Cancer

NCT03843853 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped cooperation terminated

Conditions

Colorectal Neoplasms

Interventions

DRUG: Pemetrexed
DRUG: S-1
DRUG: Bevacizumab

Sponsor

The First Affiliated Hospital with Nanjing Medical University

Collaborators

[object Object]